Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life

Overview

Journal Cancer Med

Specialty Oncology

Date 2024 Oct 28

PMID 39463009

Authors

Claire O Kisamore

Caleb A Kisamore

William H Walker 2nd

Affiliations

Soon will be listed here.

Abstract

Background: Circadian rhythms are approximately 24-hour cycles in physiological and behavioral processes. They are entrained to the external solar day via blue wavelength light. Disruptions in these intrinsic rhythms can lead to circadian dysfunction, which has several negative implications on human health, including cancer development and progression.

Aims: Here we review the molecular mechanisms of circadian disruption and their impact on tumor development and progression, discuss the interplay between circadian dysfunction and cancer in basic scientific studies and clinical data, and propose the potential clinical implications of these data that may be used to improve patient outcomes and reduce cost of treatment.

Materials & Methods: Using scientific literature databases, relevant studies were analyzed to draw overarching conclusions of the relationship between circadian rhythm dysruption and cancer.

Conclusions: Circadian disruption can be mediated by a number of environmental factors such as exposure to light at night, shift work, jetlag, and social jetlag which drive oncogenesis. Tumor growth and progression, as well as treatment, can lead to long-term alterations in circadian rhythms that negatively affect quality of life in cancer survivors.

References

Khorkova O, Stahl J, Joji A, Volmar C, Wahlestedt C . Amplifying gene expression with RNA-targeted therapeutics. Nat Rev Drug Discov. 2023; 22(7):539-561. PMC: 10227815. DOI: 10.1038/s41573-023-00704-7. View

Berger A, Hertzog M, Geary C, Fischer P, Farr L . Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors. J Cancer Surviv. 2012; 6(3):305-14. DOI: 10.1007/s11764-012-0218-x. View

Farshadi E, van der Horst G, Chaves I . Molecular Links between the Circadian Clock and the Cell Cycle. J Mol Biol. 2020; 432(12):3515-3524. DOI: 10.1016/j.jmb.2020.04.003. View

Hsu C, Lin P, Lai C, Lin H, Lin S, Yang M . PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma. Head Neck. 2013; 36(7):1018-26. DOI: 10.1002/hed.23402. View

de Assis L, Sarti Kinker G, Moraes M, Markus R, Fernandes P, Castrucci A . Expression of the Circadian Clock Gene Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma. Front Oncol. 2018; 8:185. PMC: 6005821. DOI: 10.3389/fonc.2018.00185. View

Extra J, Espie M, Calvo F, Ferme C, Mignot L, Marty M . Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemother Pharmacol. 1990; 25(4):299-303. DOI: 10.1007/BF00684890. View

. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

Nomura M, Hosokai T, Tamaoki M, Yokoyama A, Matsumoto S, Muto M . Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy. Esophagus. 2023; 20(4):722-731. PMC: 10123478. DOI: 10.1007/s10388-023-01006-y. View

Erren T, Pape H, Reiter R, Piekarski C . Chronodisruption and cancer. Naturwissenschaften. 2008; 95(5):367-82. DOI: 10.1007/s00114-007-0335-y. View

10.

Hwang-Verslues W, Chang P, Jeng Y, Kuo W, Chiang P, Chang Y . Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proc Natl Acad Sci U S A. 2013; 110(30):12331-6. PMC: 3725072. DOI: 10.1073/pnas.1222684110. View

11.

Cardinali D, Brown G, Pandi-Perumal S . Chronotherapy. Handb Clin Neurol. 2021; 179:357-370. DOI: 10.1016/B978-0-12-819975-6.00023-6. View

12.

Karaboue A, Collon T, Pavese I, Bodiguel V, Cucherousset J, Zakine E . Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer. Cancers (Basel). 2022; 14(4). PMC: 8870559. DOI: 10.3390/cancers14040896. View

13.

Quante M, Mariani S, Weng J, Marinac C, Kaplan E, Rueschman M . Zeitgebers and their association with rest-activity patterns. Chronobiol Int. 2018; 36(2):203-213. PMC: 6492024. DOI: 10.1080/07420528.2018.1527347. View

14.

Fonken L, Aubrecht T, Melendez-Fernandez O, Weil Z, Nelson R . Dim light at night disrupts molecular circadian rhythms and increases body weight. J Biol Rhythms. 2013; 28(4):262-71. PMC: 4033305. DOI: 10.1177/0748730413493862. View

15.

Hadden H, Soldin S, Massaro D . Circadian disruption alters mouse lung clock gene expression and lung mechanics. J Appl Physiol (1985). 2012; 113(3):385-92. PMC: 3426166. DOI: 10.1152/japplphysiol.00244.2012. View

16.

Harding B, Palomar-Cros A, Valentin A, Espinosa A, Sanchez de Miguel A, Castano-Vinyals G . Comparing Data from Three Satellites on Artificial Light at Night (ALAN): Focusing on Blue Light's Influence on Colorectal Cancer in a Case-Control Study in Spain. Environ Health Perspect. 2024; 132(5):57702. PMC: 11100459. DOI: 10.1289/EHP14414. View

17.

Rousseau A, Tagliamento M, Auclin E, Aldea M, Frelaut M, Levy A . Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Eur J Cancer. 2023; 182:107-114. DOI: 10.1016/j.ejca.2023.01.007. View

18.

Hadadi E, Taylor W, Li X, Aslan Y, Villote M, Riviere J . Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nat Commun. 2020; 11(1):3193. PMC: 7314789. DOI: 10.1038/s41467-020-16890-6. View

19.

Pesch B, Harth V, Rabstein S, Baisch C, Schiffermann M, Pallapies D . Night work and breast cancer - results from the German GENICA study. Scand J Work Environ Health. 2009; 36(2):134-41. DOI: 10.5271/sjweh.2890. View

20.

Lee S, Donehower L, Herron A, Moore D, Fu L . Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One. 2010; 5(6):e10995. PMC: 2881876. DOI: 10.1371/journal.pone.0010995. View